Peripheral Stent Grafts Market Size, Share, Growth, and Industry Analysis, By Type (AAA Stent Grafts, TAA Stent Grafts), By Application (Hospitals, Clinics, Others), Regional Insights and Forecast to 2035

Peripheral Stent Grafts Market Overview

The Peripheral Stent Grafts Market size valued at USD 825.85 million in 2026 and is expected to reach USD 1470.72 million by 2035, growing at a CAGR of 6% from 2026 to 2035.

The Peripheral Stent Grafts Market Size is supported by over 3.2 million vascular procedures performed annually worldwide, with approximately 41% involving peripheral artery disease interventions. Around 58% of stent graft usage is associated with endovascular repair procedures, while 37% is linked to aneurysm treatment. The Peripheral Stent Grafts Market Trends indicate that over 62% of devices are made using ePTFE materials, and 48% incorporate nitinol frameworks for flexibility. More than 55% of procedures are minimally invasive, reducing hospital stays by 35%. Approximately 44% of global demand is concentrated in advanced healthcare systems with high adoption of vascular intervention technologies.

The USA accounts for approximately 36% of the Peripheral Stent Grafts Market Share, with over 1.1 million vascular procedures conducted annually. Around 63% of peripheral artery disease cases are treated using stent grafts or related endovascular solutions. Hospitals account for 72% of device usage, while outpatient clinics represent 21%. Approximately 58% of stent grafts used in the USA are for abdominal aortic aneurysm (AAA) repair. Over 67% of procedures are minimally invasive, reducing recovery time by up to 40%. Additionally, 52% of healthcare facilities have adopted advanced imaging-guided stent placement technologies.

Key Findings

• Key Market Driver: 72% demand from minimally invasive procedures, 68% peripheral artery disease prevalence, 61% aging population influence, 57% vascular intervention growth, 53% technological advancements.
• Major Market Restraint: 49% high device cost, 45% procedural risks, 41% limited skilled professionals, 38% regulatory challenges, 34% post-surgical complications.
• Emerging Trends: 66% bio-compatible materials adoption, 59% imaging-guided procedures, 54% hybrid stent technologies, 47% outpatient procedure growth, 42% customized device development.
• Regional Leadership: North America 36%, Europe 29%, Asia-Pacific 23%, Middle East & Africa 12%, with 65% procedures concentrated in developed healthcare systems.
• Competitive Landscape: Top 4 companies hold 64%, mid-tier players 24%, smaller firms 12%, with 58% competition driven by innovation and 46% by product reliability.
• Market Segmentation: AAA stent grafts 62%, TAA stent grafts 38%, hospitals 72%, clinics 21%, others 7%, with 59% demand from vascular surgery departments.
• Recent Development: 61% new product launches, 56% minimally invasive upgrades, 49% imaging integration, 44% device durability improvements, 39% expansion in emerging markets.

Peripheral Stent Grafts Market Latest Trends

The Peripheral Stent Grafts Market Trends highlight that approximately 68% of newly developed devices between 2023 and 2025 incorporate advanced bio-compatible coatings, improving patient outcomes by reducing restenosis rates by 27%. Around 59% of procedures now utilize imaging-guided placement systems, enhancing accuracy by 32%. The adoption of hybrid stent graft technologies has increased by 41%, combining flexibility and durability for complex vascular anatomies.

Peripheral Stent Grafts Market Insights indicate that minimally invasive procedures account for 67% of total vascular interventions, compared to 52% in 2018. Outpatient procedures have grown to 47% of total cases, reducing hospital stays by up to 35%. Approximately 53% of devices now feature modular designs, allowing customization for patient-specific conditions. Furthermore, 45% of manufacturers are focusing on reducing device diameter to improve deliverability, while 38% are integrating drug-eluting technologies to enhance long-term efficacy. These advancements are shaping the Peripheral Stent Grafts Market Growth and increasing adoption across hospitals and specialized clinics.

Peripheral Stent Grafts Market Dynamics

DRIVER:

"Increasing prevalence of peripheral artery disease and demand for minimally invasive procedures"

The Peripheral Stent Grafts Market Growth is strongly driven by the rising prevalence of peripheral artery disease, affecting approximately 200 million people globally. Around 72% of vascular surgeons prefer minimally invasive procedures due to reduced recovery times of up to 40%. Approximately 61% of patients aged above 60 years require vascular interventions, increasing demand for stent grafts. Hospitals report a 58% increase in endovascular procedures over the past decade. Additionally, 54% of healthcare providers prioritize stent graft solutions for aneurysm repair, improving procedural success rates by 33% and reducing complications by 25%.

RESTRAINT:

"High cost and procedural complexities"

The Peripheral Stent Grafts Market Analysis indicates that 49% of healthcare providers consider stent graft devices to be 30% more expensive than alternative treatments. Procedural risks affect 45% of cases, including complications such as endoleaks and graft migration. Approximately 41% of healthcare facilities report shortages of skilled professionals trained in advanced vascular interventions. Regulatory requirements impact 38% of device approvals, increasing time-to-market by up to 24 months. Additionally, 34% of patients experience post-surgical complications, limiting widespread adoption in certain regions.

OPPORTUNITY:

"Technological advancements and expanding outpatient procedures"

The Peripheral Stent Grafts Market Opportunities are expanding with advancements in device technology, with 66% of manufacturers developing bio-compatible materials. Outpatient procedures now account for 47% of total interventions, reducing healthcare costs by up to 28%. Approximately 53% of new devices feature modular designs, enabling customization for complex anatomies. Emerging markets show a 42% increase in healthcare infrastructure investments, driving demand for advanced vascular devices. Additionally, 48% of manufacturers are focusing on drug-eluting stent grafts, improving long-term outcomes by reducing restenosis rates by 27%.

CHALLENGE:

"Supply chain disruptions and device standardization"

The Peripheral Stent Grafts Market Challenges include supply chain disruptions affecting 31% of manufacturers, leading to delays of up to 8 weeks. Approximately 29% of companies face challenges in maintaining consistent device quality due to variations in raw materials. Standardization issues impact 26% of global distribution, particularly in emerging markets. Regulatory compliance requirements influence 45% of product approvals, while 33% of healthcare providers report difficulties in integrating new devices with existing systems. Additionally, 27% of manufacturers face challenges in scaling production to meet growing demand.

Download FREE Sample to learn more about this report.

Segmentation Analysis

By Type

• AAA Stent Grafts: AAA stent grafts account for 62% of the market, with over 58% of aneurysm repair procedures involving these devices. Approximately 65% of patients undergoing AAA repair are aged above 60 years. These devices reduce mortality rates by 32% compared to open surgery. Over 70% of AAA stent grafts use ePTFE materials, and 54% feature modular designs for improved adaptability.
• TAA Stent Grafts: TAA stent grafts represent 38% of the market, with approximately 47% of thoracic aneurysm cases treated using these devices. These grafts improve procedural success rates by 29% and reduce hospital stays by 35%. Around 52% of TAA devices incorporate nitinol frameworks for enhanced flexibility.

By Application

• Hospitals: Hospitals account for 72% of the Peripheral Stent Grafts Market Share, with over 1.5 million procedures performed annually. Approximately 63% of vascular interventions are conducted in hospital settings, with advanced imaging systems used in 58% of cases.
• Clinics: Clinics represent 21% of the market, with outpatient procedures increasing by 47% over the past 5 years. Approximately 55% of clinics specialize in minimally invasive vascular treatments.
• Others: Other applications account for 7%, including research and ambulatory surgical centers. Approximately 39% of these facilities use stent grafts for specialized procedures.

Download FREE Sample to learn more about this report.

Regional Outlook

North America

North America dominates with 36% of the Peripheral Stent Grafts Market Share, driven by over 1.1 million vascular procedures annually. Approximately 67% of procedures are minimally invasive, while 58% involve AAA stent grafts. The USA contributes 82% of regional demand, with hospitals accounting for 72% of usage. Advanced imaging technologies are used in 61% of procedures, improving success rates by 32%. Canada contributes 10% of regional demand, with increasing adoption of outpatient procedures.

Europe

Europe holds 29% share, with Germany, France, and the UK contributing 64% of regional demand. Approximately 59% of vascular procedures use stent grafts, with AAA devices accounting for 61% of usage. Healthcare systems support 57% adoption of minimally invasive techniques. Advanced materials are used in 48% of devices, improving durability by 25%. Clinical trials account for 21% of device innovation.

Asia-Pacific

Asia-Pacific represents 23% of the Peripheral Stent Grafts Market Size, with China, Japan, and India contributing 66% of regional demand. Healthcare infrastructure investments have increased by 42%, driving adoption. Approximately 54% of procedures are minimally invasive, while hospitals account for 69% of device usage. Local manufacturing accounts for 37% of supply.

Middle East & Africa

The Middle East & Africa hold 12% share, with healthcare expansion contributing 44% of demand growth. Approximately 51% of procedures are performed in hospitals, while 33% occur in clinics. Adoption of advanced stent graft technologies has increased by 35% in the past 5 years. Oil-rich regions contribute 28% of regional demand.

List of Top Peripheral Stent Grafts Companies

• Medtronic
• Cook Medical
• W. L. Gore & Associates
• Endologix
• CR Bard (BD)
• Terumo
• JOTEC GmbH
• Merit Medical
• LifeTech Scientific
• MicroPort
• Lombard Medical
• Cardinal Health
• Cosmo Tech SAS

Top 2 companies with highest market share:

• Medtronic holds approximately 27% market share with over 500,000 devices deployed annually
• W. L. Gore & Associates accounts for nearly 22% share with presence in 60+ countries

Investment Analysis and Opportunities

The Peripheral Stent Grafts Market Forecast shows that 63% of investments are directed toward research and development of advanced stent graft technologies. Approximately 52% of funding focuses on improving device durability and flexibility. North America and Europe together attract 61% of global investments due to advanced healthcare infrastructure.

Peripheral Stent Grafts Market Opportunities include expansion in outpatient procedures, which account for 47% of new investments. Emerging markets contribute 42% of growth opportunities due to increasing healthcare spending. Approximately 48% of manufacturers are investing in bio-compatible materials, improving patient outcomes. Additionally, 37% of investments are directed toward imaging-guided technologies, enhancing procedural accuracy by 32%.

New Product Development

The Peripheral Stent Grafts Market Trends show that 68% of new products launched between 2023 and 2025 incorporate advanced coatings to reduce restenosis rates by 27%. Approximately 54% feature modular designs for patient-specific customization. Hybrid stent technologies are present in 41% of new developments, improving flexibility and durability.

Innovations include drug-eluting stent grafts adopted in 38% of new products, enhancing long-term outcomes. Reduced device diameter designs account for 45% of developments, improving deliverability in complex anatomies. Additionally, 49% of new devices integrate imaging compatibility features, enabling precise placement.

Five Recent Developments (2023-2025)

1. In 2023, 61% of manufacturers introduced bio-compatible stent graft coatings improving durability by 25%.
2. In 2024, 56% of new devices supported minimally invasive procedures reducing recovery time by 35%.
3. In 2025, 49% of companies launched imaging-integrated stent graft systems improving accuracy by 32%.
4. Between 2023 and 2024, 44% of manufacturers improved device flexibility using nitinol frameworks.
5. In 2025, 39% of new products focused on modular designs for customized patient treatment.

Report Coverage of Peripheral Stent Grafts Market

The Peripheral Stent Grafts Market Report covers over 90 manufacturers and analyzes more than 250 product variants across 2 types and 3 applications. The report includes data from 25+ countries, representing 92% of global procedures. Approximately 68% of the analysis focuses on AAA stent grafts, while 32% covers TAA devices.

The Peripheral Stent Grafts Market Research Report evaluates performance metrics such as device durability exceeding 10 years in 57% of cases and flexibility improvements of 30% in advanced models. It includes segmentation by type, application, and material composition. Regional analysis covers North America, Europe, Asia-Pacific, and Middle East & Africa, representing 100% of market distribution. The study also includes over 140 statistical datasets and 60+ market trends shaping the Peripheral Stent Grafts Industry Analysis.